TABLES
TABLE 1 GLOBAL BIOSIMILARS MARKET REVENUE BY REGIONS' 2017-2024 ($MILLION) 50
TABLE 1 GLOBAL BIOSIMILARS MARKET BY VENDOR RANKING' 2017 61
TABLE 2 OTHER PROMINENT VENDORS OF BIOSIMILARS MARKET 62
TABLE 3 PFIZER' INC.: OFFERINGS 63
TABLE 4 PFIZER' INC.: RECENT DEVELOPMENTS 64
TABLE 5 NOVARTIS AG: PRODUCT OFFERINGS 69
TABLE 6 NOVARTIS AG: RECENT DEVELOPMENTS 69
TABLE 7 NOVARTIS AG: OVERVIEW SNAPSHOT 71
TABLE 8 CELLTRION HEALTHCARE: OFFERINGS 76
TABLE 9 CELLTRION HEALTHCARE: RECENT DEVELOPMENTS 76
TABLE 10 DR' REDDY'S LABORATORIES LIMITED: PRODUCT OFFERINGS 81
TABLE 11 DR. REDDY'S LABORATORIES LIMITED: RECENT DEVELOPMENTS 82
TABLE 12 BIOCON LTD: PRODUCT OFFERINGS 89
TABLE 13 BIOCON LTD: RECENT DEVELOPMENTS 90
TABLE 14 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCT OFFERINGS 95
TABLE 15 TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS 95
TABLE 16 STADA ARZNEIMITTEL AG: PRODUCT OFFERINGS 100
TABLE 17 STADA ARZNEIMITTEL AG: RECENT DEVELOPMENTS 101
TABLE 18 AMGEN INC.: SNAPSHOT 106
TABLE 19 AMGEN INC.: RECENT DEVELOPMENTS 106
TABLE 20 MYLAN N.V.: SNAPSHOT 110
TABLE 21 SYNTHON PHARMACEUTICALS: SNAPSHOT 111
TABLE 22 SAMSUNG BIOEPIS CO.' LTD: SNAPSHOT 112

?

LIST OF FIGURE

CHARTS
CHART 1 RESEARCH METHODOLOGY OF GLOBAL BIOSIMILARS MARKET 13
CHART 2 GLOBAL BIOSIMILARS MARKET REVENUE' 2017-2024 ($MILLION) 16
CHART 3 NUMBER OF BIOSIMILARS APPROVED FROM 2006-2017 27
CHART 4 SEGMENTATION OF GLOBAL BIOSIMILARS MARKET 29
CHART 5 PEST ANALYSIS OF GLOBAL BIOSIMILARS MARKET 29
CHART 6 PORTER 5 FORCES ON GLOBAL BIOSIMILARS MARKET 30
CHART 7 DRO - IMPACT ANALYSIS OF GLOBAL BIOSIMILARS MARKET 36
CHART 8 KEY STAKEHOLDERS 37
CHART 9 GLOBAL BIOSIMILARS MARKET BY PRODUCT SEGMENTATION' 2017 (%) 39
CHART 10 GLOBAL RECOMBINANT GLYCOSYLATED PROTEIN MARKET FORECAST' 2017-2024 ($MILLION) 40
CHART 11 GLOBAL RECOMBINANT GLYCOSYLATED PROTEIN MARKET BY TYPE SEGMENTATION' 2017 (%) 40
CHART 12 GLOBAL RECOMBINANT NON-GLYCOSYLATED PROTEIN MARKET FORECAST' 2017-2024 ($MILLION) 42
CHART 13 GLOBAL RECOMBINANT NON-GLYCOSYLATED PROTEIN MARKET BY TYPE SEGMENTATION' 2017 (%) 43
CHART 14 GLOBAL RECOMBINANT PEPTIDE AND OTHERS MARKET FORECAST' 2017-2024 ($MILLION) 45
CHART 15 GLOBAL BIOSIMILARS MARKET BY APPLICATION SEGMENTATION' 2017 (%) 46
CHART 16 GLOBAL BIOSIMILARS MARKET BY GEOGRAPHICAL SEGMENTATION' 2017 (%) 51
CHART 17 BIOSIMILARS MARKET REVENUE IN NORTH AMERICA' 2017-2024 ($MILLION) 52
CHART 18 BIOSIMILARS MARKET REVENUE IN EUROPE' 2017-2024 ($MILLION) 54
CHART 19 BIOSIMILARS MARKET REVENUE IN ASIA PACIFIC' 2017-2024 ($MILLION) 57
CHART 20 BIOSIMILARS MARKET REVENUE IN REST OF THE WORLD' 2017-2024 ($MILLION) 60
CHART 21 PFIZER' INC.: OVERVIEW SNAPSHOT 66
CHART 22 PFIZER INC.: BUSINESS UNITS 67
CHART 23 PFIZER INC.: GEOGRAPHIC PRESENCE 68
CHART 24 PFIZER INC: SWOT ANALYSIS 69
CHART 25 NOVARTIS AG: BUSINESS UNITS 73
CHART 26 NOVARTIS AG: GEOGRAPHIC REVENUE 74
CHART 27 NOVARTIS AG: SWOT ANALYSIS 75
CHART 28 CELLTRION HEALTHCARE: OVERVIEW SNAPSHOT 78
CHART 29 CELLTRION HEALTHCARE: BUSINESS SEGMENTS 79
CHART 30 CELLTRION HEALTHCARE: SWOT ANALYSIS 81
CHART 31 DR. REDDY'S LABORATORY LIMITED: OVERVIEW SNAPSHOT 86
CHART 32 DR. REDDY'S LABORATORY LIMITED: BUSINESS UNITS 87
CHART 33 DR. REDDY'S LABORATORY LIMITED: GEOGRAPHICAL PRESENCE 87
CHART 34 DR. REDDY'S LABORATORY LIMITED: SWOT ANALYSIS 89
CHART 35 BIOCON LTD: OVERVIEW SNAPSHOT 92
CHART 36 BIOCON LTD: BUSINESS UNITS 93
CHART 37 BIOCON LTD: GEOGRAPHICAL PRESENCE 93
CHART 38 BIOCON LTD: SWOT ANALYSIS 94
CHART 39 TEVA PHARMACEUTICAL INDUSTRIES LTD: OVERVIEW SNAPSHOT 97
CHART 40 TEVA PHARMACEUTICAL INDUSTRIES LTD: BUSINESS UNITS 98
CHART 41 TEVA PHARMACEUTICAL INDUSTRIES LTD: GEOGRAPHICAL PRESENCE 99
CHART 42 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 100
CHART 43 STADA ARZNEIMITTEL AG: OVERVIEW SNAPSHOT 102
CHART 44 STADA ARZNEIMITTEL AG: BUSINESS UNITS 103
CHART 45 STADA ARZNEIMITTEL AG: GEOGRAPHICAL PRESENCE 104
CHART 46 STADA ARZNEIMITTEL AG: SWOT ANALYSIS 105